Analystreport

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) had its price target raised by analysts at Barclays PLC from $29.00 to $31.00. They now have an "overweight" rating on t

Syndax Pharmaceuticals, Inc.  (SNDX) 
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.syndax.com